The preclinical discovery and development of oral miltefosine for the treatment of visceral leishmaniasis: a case history (2020)
Attributed to:
A Global Network for Neglected Tropical Diseases
funded by
GCRF
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1080/17460441.2020.1743674
PubMed Identifier: 32202449
Publication URI: http://europepmc.org/abstract/MED/32202449
Type: Journal Article/Review
Parent Publication: Expert Opinion on Drug Discovery
Issue: 6
ISSN: 1746-0441